Pfizer (NYSE: PFE)
Pfizer Return vs. S&P
1 Year | 5 Year | 5 Year Annualized | Since IPO |
---|
Pfizer Company Info
Pfizer Inc. is a research-based global biopharmaceutical company. It engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.
News & Analysis
3 Stocks to Buy for Huge Income
All 3 of these stocks have a yield above 5%.
Is Pfizer the Best Dividend Stock for You?
Short-term expectation worries have elevated Pfizer's dividend yield.
Is Pfizer an Excellent Dividend Stock to Buy for Passive Income Investors?
Pfizer's dividend yield is rising as the stock price is falling.
How Much Will Pfizer Pay Out in Dividends This Year?
As one of the world's largest drugmakers, Pfizer generates lots of cash it can share with investors.
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever
Going against the grain here looks like a great idea.
3 Stocks That Can Help You to Get Richer in 2025 and Beyond
These are three solid contenders for your portfolio.
1 Top Dividend Stock to Load Up On Now
This deeply undervalued pharma stock is a top buy.
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
Pfizer stock lost nearly half its value over the past couple of years, but some of the world's most successful investors bought millions of shares in the first quarter.
Valuation
Podcast Episodes
A Coronavirus Vaccine Is Good News. What's Going on With Cruise Lines?
A look at stock market news.
Why Is a Coronavirus Vaccine Bad News for Some Stocks?
Investors knew that a vaccine was coming, so why did the market react the way it did?
Why Coronavirus Vaccine News Is Great for Bank Stocks and REITs
Some of our favorite banks and real estate stocks are having their best rallies in years.
2 Reasons Pfizer Is on Our Minds Today
First, it raised some spinoff speculation. Second, it's in an intriguing tussle with J&J that could affect the biosimilars market for everyone.
Earnings Transcripts
Pfizer (PFE) Q1 2024 Earnings Call Transcript
PFE earnings call for the period ending March 31, 2024.
Pfizer (PFE) Q4 2023 Earnings Call Transcript
PFE earnings call for the period ending December 31, 2023.
Pfizer (PFE) Q3 2023 Earnings Call Transcript
PFE earnings call for the period ending September 30, 2023.
Pfizer (PFE) Q2 2023 Earnings Call Transcript
PFE earnings call for the period ending June 30, 2023.
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.